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Abstract
Aim: Recent evidence suggests that arterial hypertension could be alternatively explained 
as a physiological adaptation response to water shortage, termed aestivation, which relies 
on complex multi- organ metabolic adjustments to prevent dehydration. Here, we tested 
the hypothesis that chronic water loss across diseased skin leads to similar adaptive water 
conservation responses as observed in experimental renal failure or high salt diet.
Methods: We studied mice with keratinocyte- specific overexpression of IL- 17A 
which develop severe psoriasis- like skin disease. We measured transepidermal water 
loss and solute and water excretion in the urine. We quantified glomerular filtration 
rate (GFR) by intravital microscopy, and energy and nitrogen pathways by metabo-
lomics. We measured skin blood flow and transepidermal water loss (TEWL) in con-
junction with renal resistive indices and arterial blood pressure.
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1 |  INTRODUCTION
Current opinion maintains that an important cause of ar-
terial hypertension is an inability of the kidneys to excrete 
sufficient amounts of salt and water, which functionally 
couples with an increase in blood vessel tone, and thereby 
ultimately increases blood pressure. Supporters of the under-
lying pressure- natriuresis theory for renal long- term blood 
pressure control contend that adaptive- physiological body 
responses designed to prevent salt overload and body overhy-
dration provide a unifying pathophysiological explanation for 
any form of chronic blood pressure increase.1- 3
Re- testing this widely accepted notion in rats with ex-
perimental chronic renal failure, we found that “renal” hy-
pertension was not explained by an inability of the kidneys 
to excrete sufficient amounts of salt and water.4 In contrast 
with the renal salt and water retention theory, we found 
our rats with experimental kidney mass reduction that the 
remaining rest of their renal epithelial barrier was able to 
release the correct amount of salt, but unable to sufficiently 
conserve water. The resulting “renal” hypertension was 
caused by an evolutionary- preserved adaptive aestivation- 
like response designed to prevent body dehydration, which 
utilizes constriction of blood vessels to limit extrarenal 
water loss.5 Across the animal kingdom, aestivators rely 
on various hepato- reno- dermal water conservation strate-
gies (metabolic aestivation motifs), which allow them to 
produce and recycle the solutes necessary to keep water 
in their body.6- 8 In addition, water- conserving aestivators 
centralize their circulation (circulatory aestivation motifs) 
to reduce water loss across the biological barriers, skin and 
kidney, to a minimum.5,9,10
Here, we tested the hypothesis that chronic water loss 
across the diseased skin might similarly lead to arterial hy-
pertension and muscle mass loss. We show that mice with 
a psoriasis- like skin barrier disorder lose large amounts of 
water across their disrupted keratinocyte barrier. In analogy 
to chronic renal failure, this cutaneous water loss triggers var-
ious metabolic and circulatory aestivation- like responses that 
lead to arterial hypertension, and metabolic aestivation- like 
adaptation responses that lead to parallel catabolic muscle 
wasting.
2 |  RESULTS
2.1 | Transepidermal water loss in 
experimental psoriasis leads to dehydration
Mammals maintain body fluid balance via concerted action 
of the four biological barriers kidneys, lung, gut and skin. 
With an area of approximately 2 m2 in adults, the skin is the 
largest organ of the human body.11,12 The intact skin barrier 
is relatively impermeable for water, however, transepider-
mal water loss is significant in injured or diseased skin.13 
Our mouse model of psoriasis mimics the skin phenotype of 
human psoriasis14 with its typical features such as hyper- and 
parakeratosis, thickening of the epidermal and dermal layer, 
and influx of myeloid cells (Figure 1A,B). Patients with pso-
riasis show increased transepidermal water loss (TEWL) 
across their psoriatic plaques.15 We tested the hypothesis 
that psoriatic mice suffer from significant water loss across 
their defective epidermal barrier, which may predispose to 
dehydration.
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Results: Psoriatic animals lost large amounts of water across their defective cutane-
ous epithelial barrier. Metabolic adaptive water conservation included mobilization 
of nitrogen and energy from muscle to increase organic osmolyte production, solute- 
driven maximal anti- diuresis at normal GFR, increased metanephrine and angiotensin 
2 levels, and cutaneous vasoconstriction to limit TEWL. Heat exposure led to cutane-
ous vasodilation and blood pressure normalization without parallel changes in renal 
resistive index, albeit at the expense of further increased TEWL.
Conclusion: Severe cutaneous water loss predisposes psoriatic mice to lethal dehy-
dration. In response to this dehydration stress, the mice activate aestivation- like water 
conservation motifs to maintain their body hydration status. The circulatory water 
conservation response explains their arterial hypertension. The nitrogen- dependency 
of the metabolic water conservation response explains their catabolic muscle wasting.
K E Y W O R D S
aestivation, catabolism, dehydration, double barrier concept, hypertension, transepidermal water 
loss
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Similar to patients with psoriasis (Figure  1C), K14- IL- 
17Aind/+ animals with keratinocyte- specific overexpression 
of the cytokine Interleukin- 17A (IL- 17A) (see method sec-
tion for details) which develop severe psoriasis- like skin dis-
ease, showed increased transepidermal water loss across their 
psoriatic lesions (Figure  1D). Across the non- affected skin 
regions, K14- IL17Aind/+ psoriatic mice showed lower TEWL 
than their healthy littermate controls (Figure 1D), suggesting 
a compensatory reduction of TEWL in their intact skin to 
reduce total skin water loss. However, considering the extent 
of affected skin surface, mice with severe psoriasis lost in 
total a calculated amount of 2.3 ± 0.5 mL more water per 
day through their skin barrier than control mice. Therefore, 
K14- IL- 17Aind/+ mice lost daily ≈ 41% ± 10% of their total 
body water content across their skin, compared to 15% ± 5% 
in IL- 17Aind/+ control animals with intact skin (Figure 1E and 
Table S1).
These findings suggest that psoriatic mice have a tran-
sepidermal barrier defect, which leads to significant skin 
water loss and predisposes the animals to dehydration. 
Physiological adaptation to water shortage, termed aestiva-
tion, is an evolutionarily conserved survival strategy that re-
lies on complex physiologic- metabolic adjustment to prevent 
otherwise severe dehydration.16 We next tested the hypothe-
sis that K14- IL- 17Aind/+ mice utilized circulatory and meta-
bolic aestivation motifs to stabilize their body water content.
F I G U R E  1  Psoriasis disrupts the skin barrier in human patients and K14- IL- 17Aind/+ mice, which increases transepidermal water loss. A, 
H&E stained skin sections from non- lesional and lesional human psoriatic skin. Scale bars equal 200 µm. B, H&E stained skin sections from 
healthy skin of IL- 17Aind/+ littermates and skin lesions from K14- IL- 17Aind/+ mice. Scale bars equal 200 µm. C, Quantification of transepidermal 
water loss (TEWL) in skin of psoriatic patients (n = 10). D, Quantification of TEWL in healthy skin of IL- 17Aind/+ littermates (n = 11) and skin 
of K14- IL- 17Aind/+ mice (n = 11). E, Estimate of daily TEWL, calculated as percentage of total body water in the same mice. For complete data 
and full calculations see Online Table S1. Data analysis by Student's t- test for independent or dependent samples. Data are shown as mean ± SEM. 
*P < .05; ‡P < .001
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2.2 | Aestivation motif 1: Reduction in 
renal solute and water excretion results in 
adaptive oligo- anuria for stabilization of body 
water content
Organisms that suffer from dehydration increase their fluid 
intake and reduce their urine volume to achieve a positive 
water balance. We hypothesized that besides limiting skin 
blood flow, K14- IL- 17Aind/+ mice limited renal water loss to 
compensate for their excessive skin water loss (Figure 1D,E).
Compared to healthy littermates, mice with psoriasis- 
like skin disease increased their 24- hours water intake and 
in parallel maximally reduced their 24- hours urine excre-
tion (Figure 2A). Renal barrier function is characterized by 
initial water loss because of the glomerular filtration, which 
is necessary to eliminate surplus body solutes. Most of the 
filtered solutes are then reabsorbed in the tubular system, 
mainly as Na+ (with accompanying anions), K+ (with ac-
companying anions) and urea osmolytes. The tubular solute 
reabsorption process then generates the osmotic driving force 
necessary for successful tubular water reabsorption and urine 
concentration.17
To test the hypothesis that the massive reduction in 
urine volume formation in K14- IL- 17Aind/+ mice might be 
explained by reduced glomerular filtration rate, we imaged 
glomerular filtration and quantified tubular flow (Video 
S1 and Video S2). Compared to healthy littermates, psori-
atic mice showed similar flow rates in the proximal tubules 
F I G U R E  2  K14- IL- 17Aind/+ mice successfully compensate their dermal water loss by reducing renal solute excretion and strengthening 
their urine concentration mechanism. A, Fluid intake and urine excretion in IL- 17Aind/+ (n = 9) and K14- IL- 17Aind/+ mice (n = 6). B, Glomerular 
filtration rate, measured as proximal tubular flow rate by intravital microscopy of kidney tubules in IL- 17Aind/+ (n = 5) and K14- IL- 17Aind/+ mice 
(n = 5). C, Ultrafiltrate passage time from proximal to distal tubule in the same mice. D, Relationship between 2 Na+, 2 K+ (calculated twofold to 
account for the excretion of unmeasured accompanying anions), urea solute excretion and urine volume formation in IL- 17Aind/+ (n = 7) and K14- 
IL- 17Aind/+ mice (n = 6). E, Relationship between urine osmolality and urine volume formation in the same animals as in Panel D. Data analysis by 
simple linear regression or Student's t test for independent samples. Data are shown as mean ± SEM. *P < .05; ‡P < .001
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(Figure  2B), indicating normal glomerular filtration rate. 
In line with these functional intra- vital findings, histology 
showed no evidence of kidney damage (Figure S1A,B), and 
the mice had no proteinuria (Figure S1C). We measured lon-
ger passage times of the primary filtrate from proximal to 
distal tubules in K14- IL- 17Aind/+ mice (Figure 2C), indicat-
ing reduced tubular flow rates despite similar glomerular fil-
tration rate. We conclude that K14- IL- 17Aind/+ mice reduced 
their urine volume to almost anuric levels by massive tubular 
water reabsorption.
Compared to their littermate controls, psoriatic animals 
reduced the amount of daily excreted Na+, K+ and urea sol-
utes (cation osmolyte excretion calculated twofold to ac-
count for accompanying anions), by 66.2% (Figure 2D), and 
thereby prevented osmotic diuresis. Furthermore, psoriatic 
mice showed a two- to sixfold increase in urine osmolality, 
indicating further urine volume reduction by maximum urine 
concentration (Figure 2E) and a reduction in 24- hours Na+, 
K+, and urea solute excretion (Figure S2A). The relative con-
tribution of the excreted Na+, K+, and urea solutes to total 
urine solute excretion revealed that psoriatic mice predomi-
nantly retained urea solutes (Figure S2B).
These findings indicate that K14- IL- 17Aind/+ mice had 
healthy kidneys which reduced solute excretion and enforced 
urine concentration for renal water conservation. We con-
clude that the animals utilized water conservation in the renal 
barrier to its physiological limits to compensate for the water 
loss that occurred across their defective skin barrier. Because 
of the predominant reduction of urinary urea in this water 
conservation process, we next studied urea metabolism in the 
kidney and the skin (Figure 3).
2.3 | Aestivation motif 2: Increased urea 
transport for water conservation in the 
epithelial kidney and skin barrier
Water conservation in the renal concentration segment relies 
on the transport of urea osmolytes by the urea transporter 
A1 (UTA- 1) in the renal medulla.18 K14- IL- 17Aind/+ mice 
showed increased UT- A1 mRNA (Figure S3A) and protein 
levels in their kidneys (Figure  3A), resulting in increased 
urea osmolyte content in the renal urine concentration seg-
ment (Figure 3B). K14- IL- 17Aind/+ mice coupled increased 
UT- A1- driven urea transport with increased aquaporin- 2 
(Aqp2) mRNA expression (Figure  3C), indicating that the 
mice facilitated urea- driven water reabsorption in the renal 
medulla by improving channel- mediated water permeability 
in the collecting duct. Increased renal water conservation by 
urine concentration in K14- IL- 17Aind/+ mice appeared to be 
UT- A1- and AQP2- specific, as mRNA- expression of UT- A2 
and the other aquaporins were not different between control 
and K14- IL- 17Aind/+ mice (Figure S3A,B).
In response to dehydration, tonicity enhancer- binding pro-
tein (TonEBP) improves the kidney's ability to concentrate the 
urine by increasing UT- A119 and AQP2 levels20 in the tubular 
cells of the collecting duct. We detected elevated TonEBP 
protein level in kidney of K14- IL- 17Aind/+ mice (Figure 3A), 
indicating that dermal water loss had strengthened their renal 
concentration mechanism in the tubular epithelium of the 
collecting duct by known responses of mammals experienc-
ing water shortage of any sort.21- 23
Similar to the findings in their water- conserving intact 
renal epithelial barrier, K14- IL- 17Aind/+ mice showed in-
creased skin UT- A1 expression (Figure  3D), resulting in 
high skin urea levels (Figure  3E). Furthermore, we found 
increased mRNA levels of Aquaporin 3 (Aqp3; Figure 3F), 
which is the most abundant aquaglyceroporin in the skin.24 
Western blot analysis and immunofluorescence stainings of 
psoriatic skin revealed increased TonEBP expression in skin 
of K14- IL- 17Aind/+ mice (Figure 3D), which was not limited 
to invading CD45- positive immune cells,25,26 but also present 
in skin keratinocytes (Figure 3G).
Besides urea, K14- IL- 17Aind/+ mice accumulated signif-
icant amounts of Na+ at the total body level (Figure S4A). 
The large Na+ accumulation was paralleled by only small 
increases in their plasma Na+ concentration (Figure  S4B) 
which confirmed previous findings.27 Despite the marked 
enhancement of UTA1 protein expression in the kidney and 
the skin, we could neither detect increased plasma urea levels 
(Figure S4B) nor elevated plasma osmolality (Figure S4C) in 
K14- IL- 17Aind/+ mice.
Compared to their healthy littermates, K14- IL- 17Aind/+ 
mice showed increased water content in their skin and their 
skinned rest carcass, resulting in increased total body water 
content (Figure 3H and Table S2). We interpret these find-
ings to show that in an effort to limit transepidermal fluid 
evaporation across their disrupted epithelial barrier, K14- 
IL- 17Aind/+ mice utilized water conservation regimes in 
their kidneys and their skin that were driven by comparable 
expression and adaptation of urea transporters and aquapo-
rins. Forslind et al have reported earlier that the epidermal 
epithelium generates electrolyte gradients which may sup-
port transepidermal water conservation.28- 34 In the absence 
of microanatomical resolution measurements of urea con-
centrations, we can only speculate that K14- IL- 17Aind/+ 
mice utilized increased cutaneous urea transport for water 
conservation across skin regions in which their epidermal 
barrier was not disrupted. Our chemical analysis (Table S2), 
however, indicates that despite substantial transepidermal 
water loss across skin areas with a disrupted epidermal 
barrier, K14- IL- 17Aind/+ mice employed multiple adaptive 
renal and extrarenal water conservation responses which 
were such powerful that their activation ultimately resulted 
in increased body water content per dry mass and per total 
weight.
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2.4 | Aestivation motif 3: Energy and 
nitrogen transfer from muscle to liver for urea 
osmolyte generation
We have reported earlier that successful water conservation, 
besides efficient transporter- mediated osmolyte accumula-
tion in the epithelial kidney barrier, additionally requires 
increased urea osmolyte synthesis in the liver.35 Such hepato- 
renal regulation of body water homeostasis links body fluid 
homeostasis with systemic energy metabolism. Increased 
production of urea and other organic osmolytes is energy 
intense and involves utilization of endogenous amino acids 
stored in muscle protein, which provide with the carbon and 
nitrogen components necessary for successful organic os-
molyte synthesis in the liver. We tested the hypothesis that 
stabilization of body water content we had observed in K14- 
IL- 17Aind/+ mice involved hepatic urea osmolyte synthesis.
Compared to their healthy controls, K14- IL- 17Aind/+ mice 
increased their food intake (2.7 ± 0.7 KJ/kg/d vs 4.1 ± 0.67 
KJ/kg/d; P  <  .01) at lower body weight (23.5  ±  4.1g v 
14.7  ±  1.9g; P  <  .01). We conclude that K14- IL- 17Aind/+ 
mice showed a catabolic metabolic state. We therefore next 
F I G U R E  3  K14- IL- 17Aind/+ mice utilize urea- and water transport mechanisms in kidney and skin to successfully prevent body dehydration. 
A, Urea transporter A1 (UT- A1) and tonicity enhancer binding protein (TonEBP) protein expression in the kidney of IL- 17Aind/+ (n = 6) and K14- 
IL- 17Aind/+ mice (n = 6). B, Urea content in the kidney of IL- 17Aind/+ (n = 12) and K14- IL- 17Aind/+ mice (n = 12). C, Expression of Aquaporin 2 
mRNA in kidneys of IL- 17Aind/+ (n = 5) and K14- IL- 17Aind/+ mice (n = 5). D, UT- A1 and TonEBP protein expression in the skin of IL- 17Aind/+ 
(n = 6) and K14- IL- 17Aind/+ mice (n = 6). E, Urea content in skin of IL- 17Aind/+ (n = 6) and K14- IL- 17Aind/+ mice (n = 6). F, Expression of 
Aquaporin 3 mRNA in skin of IL- 17Aind/+ (n = 5) and K14- IL- 17Aind/+ mice (n = 5). G, Immunofluorescence stained skin sections from healthy 
IL- 17Aind/+ control and psoriatic K14- IL- 17Aind/+ mice (red: TonEBP; green: CD- 45; blue: DAPI). Scale bars equal 50 µm. (H) Tissue water 
content in skin, carcass and whole body of IL- 17Aind/+ (n = 7) and K14- IL- 17Aind/+ (n = 7) animals. For additional data about total body and 
tissue water see Online Table S2. Data analysis by Student's t test for independent samples. Data are shown as mean ± SEM. * P < .05; †P < .01; 
‡P < .001
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studied the metabolic checkpoints of protein mobilization 
from skeletal muscle in K14- IL- 17Aind/+ mice. K14- IL- 
17Aind/+ mice showed signs of muscle catabolism with de-
creased muscle mass (Figure 4A), increased total and nuclear 
glucocorticoid receptor protein expression (Figure  4B and 
Figure S5), reduced liver glucose and mannose levels indicat-
ing gluconeogenesis with a reduction in liver glycogen stores 
(Figure 4C), and increased 3- OH- butyrate levels (Figure 4C), 
suggesting a switch from energy- intense gluconeogenesis 
to energy- efficient hepatic ketogenesis. However, despite 
this glucocorticoid- driven catabolic state, K14- IL- 17Aind/+ 
mice showed a 50% increase in liver mass (Figure 4A) with 
no signs of hepatic energy deficit, as their phosphorylated 
protein levels of the cellular energy sensor, AMP- activated 
kinase (AMPK), were not different from healthy controls 
(Figure 4D).
We next tested the hypothesis that liver hypertrophy 
might result in increased amino acid- driven ureagenesis 
for water conservation in K14- IL- 17Aind/+ mice. The met-
abolic signature of catabolic exploitation of muscle protein 
is characterized by the mobilization of the branched- chain 
amino acids (BCAAs) valine, leucine and isoleucine from 
muscle protein.25 Similarly, the muscle dipeptides anserine 
and carnosine, which serve as a muscle energy store that is 
F I G U R E  4  Nitrogen transfer from catabolic skeletal muscle results in liver hypertrophy in K14- IL- 17Aind/+ mice. A, Relative organ weight 
of gastrocnemius muscle and liver normalized to body weight of IL- 17Aind/+ (n = 6) and K14- IL- 17Aind/+ (n = 6) mice. B, Representative 
immunofluorescence staining of glucocorticoid receptor (red; left panel); and parallel glucocorticoid receptor and DAPI (blue) staining in an IL- 
17Aind/+ and a K14- IL- 17Aind/+ mouse. Scale bars equal 30 µm. C, Analysis of metabolites of hepatic energy transfer in IL- 17Aind/+ (n = 6) and 
K14- IL- 17Aind/+ (n = 6) mice. D, Hepatic protein expression of unphosphorylated (AMPK) and phosphorylated AMP- activated kinase (pAMPK) 
in liver of IL- 17Aind/+ (n = 5) and K14- IL- 17Aind/+ (n = 5) mice. Data are analysed by Student's t test for independent samples. Data are shown as 
mean ± SEM. *P < .05; †P < .01; ‡P < .001
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not integrated into muscle fibre, are exploited for energy 
and nitrogen transfer into the liver (Figure S6). We found 
increased BCAA content and reduced anserine and car-
nosine levels in K14- IL- 17Aind/+ mice (Figure 5A). K14- 
IL- 17Aind/+ mice furthermore showed increased glutamate, 
aspartate, arginine and urea levels, suggesting increased 
transamination and extrahepatic urea solute production 
in skeletal muscle (Figure 5A). Per gram tissue mass, we 
found reduced alanine levels in muscle (Figure  5A), and 
elevated aspartate and glutamate levels in the livers of 
K14- IL- 17Aind/+ mice (Figure  5B). Due to the observed 
liver hypertrophy, liver amino acid and urea content per g 
body mass were therefore 1.4- to 2.5- fold higher in K14- 
IL- 17Aind/+ mice than in controls (Figure 5C).
We finally tested for differences in the enzymatic trans-
amination machinery between K14- IL- 17Aind/+ and control 
mice. Transfer of amino acid energy from muscle to liver 
is organized by the glucose- alanine- nitrogen shuttle,36,37 
which depends on a successful transamination cascade to 
ultimately form alanine (C3- amino acid) from pyruvate 
(corresponding C3- carbon acid). Besides transamination, 
this transfer process relies on the generation of the carbonic 
acid oxaloacetate (OxA) from malate (Mal), catalysed by 
the cytoplasmatic form of the enzyme malate dehydroge-
nase (MDH1), and followed by transamination of oxaloac-
etate to aspartate (Figures S6 and S7). This transamination 
step is catalysed by the cytoplasmatic enzyme aspartate 
aminotransferase (ASAT). In muscle, K14- IL- 17Aind/+ 
mice increased their cytoplasmatic oxaloacetate (C4 car-
bonic acid) generation by increasing MDH1 enzyme activ-
ity (Figure 5D). An additional increase in ASAT enzyme 
activity (Figure 5E) promoted the generation of its corre-
sponding C4- amino acid aspartate (Figure  5A). We con-
clude that activation of the transamination machinery in 
skeletal muscle supported the generation of alanine from 
pyruvate (C3 amino acid with its corresponding carbonic 
acid), of aspartate from oxaloacetate, and of glutamate 
from α- ketoglutarate (c- 5 amino acid with its correspond-
ing carbonic acid). This catabolic process was accompa-
nied by increased arginase activity (Figure 5F), indicating 
enhanced extrahepatic urea osmolyte production from ele-
vated arginine levels. Hepatic arginase activity was 20- fold 
F I G U R E  5  Chronic skin water loss triggers liver and muscle urea osmolyte generation for water conservation. A, Analysis of metabolites 
participating in amino acid- driven mobilization of energy and nitrogen from skeletal muscle in IL- 17Aind/+ (n = 6) and K14- IL- 17Aind/+ mice 
(n = 6). B, Analysis of metabolites of hepatic nitrogen transfer per g liver tissue in the same mice. Alanine, Aspartate and Glutamate levels were 
normalized to the average level of IL- 17Aind/+ mice, Urea content is presented as non- normalized amount per g liver tissue. C, Analysis of hepatic 
metabolites per g body mass in the same mice. Alanine, Aspartate and Glutamate levels were normalized to the average level of IL- 17Aind/+ mice, 
Urea content is presented as non- normalized amount per g body mass. D, Enzyme activity of cytoplasmatic malate dehydrogenase 1 (MDH- 1); 
E, aspartate aminotransferase (ASAT) and in gastrocnemius muscle IL- 17Aind/+ (n = 6) and K14- IL- 17Aind/+ (n = 6) mice. F, Enzyme activity of 
arginase in gastrocnemius muscle and liver in the same mice as in Panel D/E. Data are analysed by Student's t test for independent samples. Data 
are shown as mean ± SEM. *P < .05; †P < .01; ‡P < .001
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higher than in skeletal muscle and elevated in K14- IL- 
17Aind/+ mice (Figure 5F). We interpret these findings to 
show the exploitation of muscle energy and nitrogen res-
ervoirs for subsequent transfer to the liver via the glucose- 
alanine- nitrogen shuttle.
2.5 | Aestivation motif 4: Circulatory 
adjustment in skin blood flow limits 
transepidermal water loss, but results in 
arterial hypertension
Systemic vasoconstriction is a fundamental physiological 
component for the maintenance of body fluid homeostasis. 
Vasoconstriction in the renal vascular beds reduces the size 
of the urine volume,38 whereas vasoconstriction of the cu-
taneous counter current vessels reduces dermal blood flow 
and thereby limits transepidermal water loss.39- 41 We tested 
the hypothesis that in an effort to prevent further water loss 
across the skin, K14- IL- 17Aind/+ mice reduced their dermal 
blood flow by vasoconstriction, and thereby reduced TEWL 
across the unaffected skin regions.
Compared to their healthy controls, K14- IL- 17Aind/+ 
mice at normal body temperature showed lower transepider-
mal water loss in skin regions without visible plaque forma-
tion (Figures  1D and 6A). In line with our hypothesis, the 
TEWL reduction in K14- IL- 17Aind/+ mice was paralleled by 
reduced pedal skin blood perfusion (Figure 6B), indicating 
increased dermal vasoconstriction for body fluid conserva-
tion. Similarly, K14- IL- 17Aind/+ mice showed increased renal 
resistance indexes, indicating parallel vasoconstriction of the 
renal vascular bed (Figure  6A). Increased vasoconstriction 
in K14- IL- 17Aind/+ mice was paralleled by increased angio-
tensin 2 and metanephrine serum levels, suggesting gener-
alized systemic vasoconstriction via hormonal and neural 
vasoconstriction signals (Figure 6C). Similar to all organisms 
with increased vascular tone, K14- IL- 17Aind/+ mice indeed 
showed increased arterial blood pressure (Figure 6A), despite 
F I G U R E  6  Dermal vasoconstriction for water conservation elevates systolic blood pressure in K14- IL- 17Aind/+ mice. A, Effect of external 
heating on blood pressure in IL- 17Aind/+ (n = 6) and K14- IL- 17Aind/+ mice (n = 6). We show parallel changes in body core temperature, TEWL 
of unaffected skin regions, renal resistive index and blood pressure. B, Representative Laser Doppler measurements of mean skin perfusion index 
of a control animal (left) and of unaffected skin from a psoriatic animal (right) at 36°C (upper) and 40°C (lower). Quantification of temperature- 
dependent changes in skin perfusion in IL- 17Aind/+ (n = 5) and K14- IL- 17Aind/+ mice (n = 5). C, Serum angiotensin II (Ang II) and metanephrine 
levels in IL- 17Aind/+ (n = 8) and K14- IL- 17Aind/+ mice (n = 8). Serum levels were normalized to the average level of all healthy animals. Data 
analysis by Student's t- test for independent or dependent samples. Data are shown as mean ± SEM. *P < .05; †P < .01; ‡P < .001
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the continuous water loss across the transepidermal barrier 
(Figure 1D,E).
Besides water conservation, the skin barrier also plays a 
key role in body temperature regulation.40 Homoeothermic 
mice vasodilate skin vessels to increase TEWL and utilize 
the resulting evaporative cooling to stabilize their body 
temperature in the heat, albeit at the expense of body water 
loss. We hypothesized that dermal vasoconstriction for cuta-
neous body fluid conservation significantly elevates blood 
pressure in K14- IL- 17Aind/+ mice. To test this hypothesis, 
we anaesthetized our mice and increased their body tem-
perature by 4°C within 15 minutes by exposure to red light. 
With elevating body temperature, both K14- IL- 17Aind/+ 
and control mice increased their skin perfusion, and the 
pre- existing difference in their skin blood mass disappeared 
(Figure 6B). The resulting steeper increase in skin perfu-
sion in K14- IL- 17Aind/+ mice normalized their systemic 
blood pressure level, albeit at the expense of increased skin 
water loss (Figure  6A). In control mice, temperature ex-
posure induced renal vasoconstriction (Figure 6A). Within 
15 minutes, control mice had increased their renal resistive 
indexes to the level of K14- IL- 17Aind/+ mice. In contrast 
with control mice, temperature exposure did not further el-
evate the pre- existing high renal resistive indexes in K14- 
IL- 17Aind/+ mice. We conclude that temperature exposure 
vasodilated skin vessels in K14- IL- 17Aind/+ mice, while 
the level of vasoconstriction in the renal vascular bed did 
not change. The temperature- induced changes in systemic 
blood pressure in K14- IL- 17Aind/+ mice therefore were not 
attributable to renal circulatory adjustment.
We interpret these findings to show that K14- IL- 17Aind/+ 
mice constricted cutaneous blood vessels in an effort to limit 
elevated water loss across their leaky epidermal barrier. This 
dermal water conservation response occurred at the expense 
of arterial hypertension.
3 |  DISCUSSION
We have found that “renal” hypertension that occurs in ex-
perimental renal failure cannot be explained easily by a body 
response that is secondary to renal water loss.4 Because this 
concept is antipodal to current understanding on the rela-
tionship between body fluid and blood pressure homeosta-
sis, we additionally tested the hypothesis that water loss 
across the disrupted skin barrier in mice with psoriasis- like 
skin disease would similarly trigger evolutionary- preserved 
aestivation- like patterns for water conservation, and explain 
hypertension.
In line with this hypothesis, we find that the hypertension 
in K14- IL- 17Aind/+ mice is explained by vasoconstriction 
of dermal blood vessels in an effort to limit transepider-
mal water loss across the disrupted epithelial barrier. We 
have previously tried to explain the arterial hypertension in 
K14- IL- 17Aind/+ mice by immune cell- driven induction of 
vascular dysfunction.27 However, our recent finding that T- 
cell- specific overexpression of IL- 17A resulted in similar 
vascular dysfunction and reactive oxygen generation with-
out exerting any blood pressure change casts doubt on the 
concept that immune cell- or interleukin- driven effects on 
the vasculature are sufficient to causally explain arterial hy-
pertension.42 Our data instead suggest that vasoconstriction 
because of reduced vascular endothelial NO synthesis and 
increased reactive oxygen species may be a logical conse-
quence of a systemic reprioritization of energy and nitrogen 
metabolism for successful water conservation by adaptive 
aestivation motifs. Our temperature exposure experiments 
additionally show that such metabolically driven vasocon-
striction for water conservation does not “clamp” blood pres-
sure in psoriatic mice at high levels. In contrast, the mice can 
rapidly abandon their dermal vasoconstriction once thermic 
energy needs to be released via the skin.
This acute change in skin vascular function is most likely 
explained by a dominating effect of sympathetic skin nerves, 
which apparently can override any underlying metabolic en-
dothelial dysfunction by rapidly reducing their discharge.43 
This hierarchy allows the organism to acutely dilate skin blood 
vessels once facilitated heat release across the skin is manda-
tory. We conclude that the idea of a dermato- renal mainte-
nance of body fluid homeostasis, which is a well- established 
aestivation motif, may provide a simple alternative view 
towards a better understanding of the underlying cause of 
arterial hypertension (Figure S8): once the dermal vasocon-
striction necessary for improved transepidermal water con-
servation is abolished, blood pressure levels normalize, albeit 
at the expense of increased skin water loss. While the effect of 
dermal skin vasodilation on increasing transepidermal water 
loss and reducing core body temperature is a well- established 
physiological concept, we cannot exclude that parallel de-
creases in cardiac output may have additionally contributed 
to the blood pressure- lowering effect that we observed in our 
mouse model of psoriasis hypertension.
We additionally show that chronic skin barrier failure in-
duces a hepato- reno- dermal aestivation motif, which consists 
of increased urea osmolyte production in liver and muscle. 
The increase in organic osmolyte production is coupled with 
increased transporter- driven urea osmolyte accumulation in 
the skin and kidney barriers to limit transepithelial water loss. 
The energy and nitrogen- intense nature of this compensatory 
increase in organic solute production explains why K14- IL- 
17Aind/+ mice live in a starvation state with catabolic mus-
cle wasting despite increased food intake. We conclude that 
chronic water loss across a defective skin or kidney barrier 
not only triggers compensatory circulatory aestivation motifs 
that will ultimately increase blood pressure, but in parallel 
causes exploitation of the energy and nitrogen reservoirs in 
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skeletal muscle. Given the fact that even mild underlying 
glucocorticoid- driven catabolic states represent a major risk 
factor for adverse cardiovascular outcome and are strong pre-
dictors of increased mortality independent of their underlying 
cause,44 we speculate that parallel catabolism might be an 
underestimated cause of adverse health events in patients and 
in experimental animals with arterial hypertension.
In summary, similar to our report in rats with chronic 
renal failure,4 our findings in mice with chronic skin barrier 
failure define adaptive body responses to prevent dehydra-
tion as the underlying cause of elevated blood pressure and 
muscle mass loss. We anticipate that preclinical and clini-
cal investigation of compensatory aestivation responses may 
shed new light on the pathogenesis of essential hypertension 
and muscle mass loss, which occur simultaneously in ageing 
populations. The skin is the largest organ of the human body; 
however, its importance as a physiological regulator of sys-
temic energy and fluid metabolism may be underrated. Our 
findings indicate that the skin is a powerful contributor to 
systemic blood pressure homeostasis, and an easily assess-
able and potentially underestimated target for hypertension 
treatment.
4 |  MATERIALS AND METHODS
4.1 | Animal studies
We conducted all animal experiments in accordance with in-
stitutional, state and federal guidelines and with permission 
of the local animal ethics committee (Responsible govern-
ment institution: Landesuntersuchungsamt Rheinland- Pfalz; 
animal experiment permission numbers G17- 1- 076 and G15- 
1- 101). Animal treatment was in accordance with the Guide 
for the Care and Use of Laboratory Animals as adopted by 
the US National Institutes of Health and was granted by the 
University Medical Center Mainz Ethics Committee. All 
mice were housed on a 12- hour light/dark cycle with con-
stant access to food and tap water. We generated K14- IL- 
17Aind/+ mice by crossing the IL- 17Aind/ind allele (resulting 
from genetically changed Bruce- stemcells and backcrossed 
to C57Bl/6J over 50 generations) to the K14- Cre allele.14 In 
K14- Cre mice, Cre- recombinase was shown to be expressed 
specifically in keratinocytes with only low background levels 
in the thymus.45 For breeding, Cre gene was maintained only 
in the male mice. In the K14- IL- 17Aind/+ mouse strain, IL- 
17A (co- expressed with EGFP, enhanced green fluorescent 
protein) is overexpressed in the skin based on Cre- mediated 
recombination. K14- IL- 17Aind/+ mice invariably develop an 
overt skin inflammation bearing many hallmark characteris-
tics of human psoriasis. As control group, we always used 
IL- 17Aind/+ litter mates with physiological IL- 17A levels and 
without skin deficits. We conducted the experiments with 
mice of 8- 12 weeks of age.
4.2 | Transepidermal water loss
We depilated the mice 48  hours before measurements to 
avoid any influence of shaving- related skin irritation on the 
measurements. The fur was removed with an electric razor 
in an area on the chest and the back with a diameter of 1cm 
each, which equalled the diameter of the probe head of the 
Tewameter device. Anaesthesia was induced in a transpar-
ent chamber (2%- 3.5% isoflurane mixed with 0.2- 0.3 L/min 
100% O2) and maintained by using a face mask (1%- 2% iso-
flurane with 0.2 L/min 100% O2) under continuous monitor-
ing of heart rate and body temperature on a heating plate, 
monitored by ECG electrodes and a rectal probe. Room tem-
perature was continuously maintained at 21.0°C. We meas-
ured Transepidermal water loss (TEWL) with a Tewameter® 
TM300 (Courage & Khazaka, Cologne, Germany) on the 
back and the chest of the mice. The Tewameter® probe meas-
ures the density gradient of the water evaporation from the 
skin indirectly, so the open chamber method can measure 
TEWL continuously without influencing the skin microen-
vironment. A microprocessor analyses the values and ex-
presses the evaporation rate in g/h/m2. We calculated body 
surface area (BSA) as 9.822 × body weight0.667.46 The fol-
lowing formula estimates daily transepidermal water loss: 
Transepidermal water loss per day in g  =  ((Area of af-
fected skin [m2]  ×  TEWL affected skin [g/h/m2])  +  (Area 
of non- affected skin [m2] × TEWL non- affected skin [g/h/
m2])) × 24 hours. We obtained the difference in total body 
water content of K14- IL- 17Aind/+ mice and healthy litter-
mates by desiccation of tissue at 100 ⁰C for 72 hours.
4.3 | Urine collection
We placed 8- 9  week old animals into metabolic cages 
(Tecniplast Metabolics, Buguggiate, Italy) for 16- 19  hours 
without access to food. We started the measurement for every 
animal at the same time of the day to avoid circardian differ-
ences. Bodyweight was measured before and after the period 
in the metabolic cage. During urine collection, mice had ad 
libitum access to water. We measured water intake, urine 
output and urine samples were collected for further analysis. 
We additionally monitored food and water consumption in 
the normal cages 24 hours before the metabolic cage experi-
ments. In order to achieve the highest accuracy possible, we 
used brand new funnels for the experiments to exclude ero-
sion of the hydrophobic coating of the funnels, which would 
lead to more adhesion of the urine to the funnel wall with 
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resulting increased evaporation. Additionally, we sealed the 
lid of the metabolic cage with adhesive tape.
4.4 | Electrolyte and osmolality 
measurements
Sodium and potassium concentrations in plasma and 
urine were measured by flame photometry by the certi-
fied Central Laboratory of the University Medical Centre 
Mainz. Plasma and urine osmolality were calculated by 
determining the freezing point depression (Loeser, Berlin, 
Germany).
4.5 | Laser Doppler perfusion imaging
For laser Doppler perfusion imaging of the skin, we used 
the PeriCam PSI NR System® (Perimed, Rommerskirchen, 
Germany). Mice underwent the same inhalation anaes-
thesia as afore mentioned and were placed on a heating 
plate in prone position. We taped the back paws firmly 
to the surface of the heating plate with the plantar side 
up, facilitating regulation of the paw temperature by the 
heating block. Temperature was monitored with an in-
frared thermometer (TW2 Pocket Infrared Thermometer 
ThermoWorks, Salt Lake City, USA). After adjustment of 
the appropriate distance for the laser, we imaged the plan-
tar side of both paws serially twice with the identical image 
size of 4.5- 4.7 × 2.4- 2.6 cm. For the first measurement, the 
heating plate was kept at room temperature (21°C), for the 
second measurement, the temperature was set to 40°C. The 
mean perfusion of both images averaged for both paws is 
presented.
4.6 | Heating experiment
Mice were depilated 48h  hours before measurements. 
We induced inhalation anaesthesia as afore mentioned 
and placed the mice on a heated table mounted on a rail 
system (Fujifilm VisualSonics, Toronto, Ontario), moni-
tored by ECG electrodes and a rectal probe. Room tem-
perature was maintained at 21.0°C. After establishing a 
stable anaesthesia monitored by heart rate and a constant 
core temperature of 36°C, we exposed the mice to red light 
at a distance of 30- 50 cm to heat the animals from 36°C 
to 40°C body core temperature within 15  minutes. Body 
core temperature was continuously monitored with a rec-
tal probe. During the heating period, TEWL was measured 
with a Tewameter® TM300 (Courage & Khazaka, Cologne, 
Germany) as described above. Furthermore, blood pressure 
and renal resistive index were measured in parallel as de-
scribed below. In preliminary studies, continuous meas-
urements with the Tewameter device on the skin of the 
animals blocked the transmission of the red light to their 
body surface. This negatively affected the heating pro-
cess. Therefore, we measured blood pressure, renal resis-
tive index and TEWL directly before the heating process, 
only once during the heating period (at minute 5) and after 
15  minutes which was the endpoint of the experiment to 
achieve a reliable temperature increase.
4.7 | Determination of blood pressure
Systolic blood pressure was obtained in mice using a tail cuff 
noninvasive blood pressure system with the CODA® High 
Throughput System (Kent Scientific, Torrington, USA) as 
previously published.47 The mice were placed on the heated 
table without a restrainer. During the heating period, we con-
tinuously performed repeated measurements over 30 seconds 
without any pauses between the measurements. We decided 
to use this way of estimating a blood pressure time course, 
because the extent of skin disease in K14- IL- 17Aind/+ mice 
did not allow us to use invasive blood measurement by tel-
emetric catheter implantation, as severe manipulations of the 
diseased skin are lethal for the animals and therefore not ap-
propriate according to the 3R- guidelines of laboratory ani-
mal handling. We accepted the limitation that systolic arterial 
pressure is more sensitive to changes in stroke volume than 
to vascular resistance. We were keen on limiting the heating 
experiment to the shortest period possible, so that the effect 
of the anaesthesia on vascular tone would not induce a blood 
pressure drop and mild hypothermia. We therefore selected 
non- invasive tail cuff measurements for comparative blood 
pressure recordings between the groups.
4.8 | Renal resistive index
For high- resolution ultrasound imaging, we used the 
Vevo3100 Imaging System (Fujifilm VisualSonics, Toronto, 
Canada). Renal perfusion was measured as published be-
fore.48,49 We placed the transducer on the abdominal area of 
the mice and acquired longitudinal images of the right kid-
ney. We visualized one lower and one upper interlobar ar-
tery with Color Doppler. Blood flow velocity in Pulse Wave 
Doppler Mode and parallel color Doppler images were ac-
quired. The mean of three measurements in two different in-
terlobar arteries each were assessed. The renal resistive index 
was calculated with the following formula: Renal resistive 
index  =  (Peak systolic velocity  −  end diastolic velocity)/
peak systolic velocity.
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4.9 | Intravital microscopy of intra- renal 
urine flow
For anaesthesia, we used midazolam (5 mg kg−1), medeto-
midine (0.5 mg kg−1) and fentanyl (0.05 mg kg−1) and fixed 
the mice on a custom- built stage. The microscope stage 
and the animals were warmed using a heating pad during 
all experimental procedures. We implanted a jugular vein 
catheter (inner diameter 0.28 mm; outer diameter 0.61 mm; 
Smiths Medical Deutschland GmbH, Grasbrunn, Germany), 
exteriorized the left kidney through a small flank incision 
and affixed the kidney to a coverslip. Tubular flow was 
visualized by an upright confocal spinning disc microscope 
(Nikon Instruments Europe, Amsterdam, Netherlands) in-
cluding a spinning disc unit (CSU- W1, Yokogawa, Tokyo, 
Japan), sCMOS 4.2 megapixels cameras (Zyla 4.2 plus, 
Oxford Instruments Andor, Abingdon, UK), 25x water im-
mersion objective (CFI- 75 Apo 25x, numerical aperture 
1.10, Nikon) and laser beamcombiner (ILE- Beamcombiner, 
Nikon). The imaging setting for the microscope (gain and 
offset for all three channels; blue, green, and red) was 
fixed throughout the experiment. For visualizing tubular 
flow, we followed the protocol of Kitamura et al50: Lucifer 
yellow (100  μg  kg−1, intravenous bolus, L0259, Merck, 
Kenilworth, USA), a dye freely filtered by glomeruli, was 
injected via the jugular catheter. Time- lapse images for tu-
bular flow measurements were taken starting directly after 
the injection via the jugular catheter. The inflow time of 
Lucifer yellow was defined as the time to peak fluorescence 
intensity and measured in proximal and distal segments of 
three spatially separated tubular lumens that showed Lucifer 
yellow the earliest in each imaging window. We measured 
the distance between the proximal and the distal point as 
well as the radius of the proximal tubule. We calculated tu-
bular flow rate: flow rate = distance × radius2 × π/(inflow 
time distal part of proximal tubule − inflow time proximal 
part of proximal tubule). Since these tubules are early seg-
ments of proximal tubules, the tubular flow time reflects 
glomerular filtration rate. We measured the passage time 
from proximal to distal tubules by taking the inflow time of 
Lucifer yellow in proximal segment of three spatially sepa-
rated proximal tubular lumens and the inflow time in three 
distal nephrons per animal.
4.10 | Tissue water content
We dissected the mice into skin and skinned carcasses and 
measured tissue water by desiccation of tissue at 100°C 
for 72 hours as reported previously.51,52 Water content was 
calculated from the difference between wet weight and dry 
weight.
4.11 | Histology
For haematoxylin and eosin staining, tissues were dissected 
and fixed in 4% paraformaldehyde, paraffin- embedded, cut 
and stained with haematoxylin and eosin according to stand-
ard protocols. Cryo- sections of the skin (5- 8 µm thickness) 
were fixed with 4%PFA and permeabilized by 0.1%- 0.2% 
Triton X- 100 for 10 minutes. After blocking with 5%BSA, 
tissue was co- stained with rabbit polyclonal antibody against 
TonEBP (PA1- 023, Invitrogen Life Technologies, Carlsbad, 
USA) and anti- CD45 (ab10558, Abcam, Cambridge, UK) 
or anti- Glucocorticoid Receptor (D6H2L, 12041, Cell 
Signaling, Cambridge, UK). After overnight incubation, 
sections were counterstained with the secondary antibodies 
(donkey anti- rabbit IgG (ab150076, Abcam), and goat anti- 
mouse IgG, (ab150116, Abcam) and mounted in anti- fading 
mounting medium for confocal laser scanning. Nuclei were 
counterstained with Hoechst 3342 (Invitrogen). Microscopy 
was performed by confocal laser scanning or by using the 
fluorescence microscope Olympus IX81 and the TSA Cy3 
and TSA Fluorescein system (Perkin Elmer, Waltham, USA) 
as recommended by the company.
4.12 | Kidney histological evaluation
One kidney per mouse was fixed and stained with haema-
toxylin and eosin. The stainings were performed by the 
Histology Core Facility of the Institute of Molecular Biology 
(University of Mainz, Germany). To determine kidney in-
jury, 10 consecutive cortical and juxtamedullary images per 
animal were taken using an Olympus IX73 microscope and 
an Olympus SC30 camera (Olympus, Tokyo, Japan) and 
were examined. Quantitative analysis of kidney injury was 
determined by semiquantitative injury scoring (ATN score: 
0, ≤5%; 1, 5%- 15%; 2, 15%- 25%; 3, 25%- 50%; 4, ≥50%). 
These examinations were performed blinded.
4.13 | Angiotensin II, metanephrine, 
creatinine and protein measurements
We measured serum angiotensin II and metanephrine levels 
by enzyme- linked immunosorbent assay with commercially 
available kits according to the manufacturer's protocols. 
(Angiotensin II: EKU02406, Biomatik, Wilmington, USA; 
Metanephrine: MBS265523, MyBioSource, San Diego, 
USA). Creatinine in urine samples was measured by a cou-
pled enzyme reaction following manufacturer's recommen-
dations (MAK080, Creatinine Assay Kit, Sigma- Aldrich). 
We measured urine protein content by Bradford assay using 
Roti- Quant (K015.1, Carl Roth, Karlsruhe, Germany). 
14 of 18 |   WILD et aL.
Proteinuria was calculated as milligram of protein per mil-
ligram of creatinine.
4.14 | Urea and enzyme activity assays
Tissue was homogenized in protein extraction reagent 
(78510, Thermo Fisher, Waltham, USA) supplemented 
with protease/phosphatase inhibitor cocktail (1861280, 
Thermo Fisher) using an Omni TH homogenizer (Omni, 
Kennesaw, USA) immediately after tissue collection. After 
homogenization, we centrifuged the samples at 15 000× g 
for 20 minutes. To extract urea from protein, the samples 
were filtered with a 10- kDa molecular weight cut- off spin 
column (UFC505096, EMD Millipore, Merck). We took 
the urea- depleted supernatant for measuring arginase ac-
tivity, malate dehydrogenase 1 activity and aspartate 
aminotransferase activity with commercially available 
kits according to the manufacturer's protocols (Arginase: 
MAK112, Sigma- Aldrich; Malate dehydrogenase 1: 
ab200009, Abcam; Aspartate aminotransferase: ab105135, 
Abcam). We measured urea concentration in urine, plasma 
and tissues by colorimetry with a urea assay kit (K375, 
BioVision, Milpitas, USA).
4.15 | Metabolomic profile analysis
4.15.1 | Sample preparation
Liver and muscle samples from K14- IL- 17Aind/+ mice 
and IL- 17Aind/+ litter mates at the age of 8  weeks, were 
washed with PBS, snap- frozen in liquid nitrogen and stored 
at −80°C till metabolites extraction. The samples of ap-
proximately 100  mg were manually grounded in liquid 
nitrogen using a mortar kept in dry ice. Ice-cold CHCl3/
MeOH (2:1) solution was added to (1 mL for 100 mg) to 
the frozen tissue powder and sonicated in an ice/water US 
bath for 5 minutes. Then, an equivalent volume (1 mL) of 
cold HPLC- grade water was added, the homogenate was 
vortex mixed for 1  minutes, kept on ice for 15  minutes, 
and centrifuged for 10 minutes at 4°C at 2000 g, separating 
the two phases (chloroform and water/methanol). The two 
fractions were collected and stored at −20°C; the extrac-
tion procedure was repeated to maximize the metabolite 
yield, and the isolated fractions were pooled. The solvents 
were removed using a speed vacuum concentrator, and the 
dry extracts were stored at −80°C until analysis. The polar 
metabolites were reconstituted in 700  μL 99.9% D2O at 
pH 7.4 phosphate buffered saline (150  mmol/L) contain-
ing 0.01% 1,1,2,2- tetradeutero- 3- trimethylsilylpropionic 
acid (TSP) as internal standard and 0.2 mmol/L NaN3 for 
microbial growth inhibition.
4.15.2 | NMR spectroscopy
Metabolic profiling has been performed using NMR spec-
troscopy. All NMR spectra were acquired on a 600 MHz 
Avance III spectrometer (Bruker, Billerica, USA) equipped 
with a B- ACS60 sample changer at temperature probe 
27°C. Sample loading, temperature stabilization, field ho-
mogeneity, pulse calibration, data acquisition and process-
ing, including Fourier transformation, phase and baseline 
correction, and axis calibration were accomplished from 
the ICONNMR program suite (TopSpin v. 3.5, Bruker 
Biospin GmbH). For each sample, 1D NOESY (noesygp-
pr1d, Bruker library) and J- resolved (JRES) spectra were 
acquired with water signal suppression during relaxation 
and mixing time. 1D NOESY spectra were recorded with 
192 free induction decays (FIDs) with 64k data points at 
a spectral width of 12335  Hz, with acquisition time of 
2.7  seconds, relaxation delay 6  seconds and mixing time 
0.010 seconds. The J- resolved spectra were acquired with 
8k points, 40 increments of 8 scans each, for a spectral 
width of 10 000 Hz and a J- coupling domain spectral width 
of 78 Hz. The NMR spectra handling was performed with 
TOPSPIN v. 3.1 software (Bruker BioSpin). Metabolite 
signals assignment was performed with the aid of the 
Chemomx software (NMR suit 8.3, Chenomx Inc) and the 
freely available electronic Human Metabolome Database 
(HMDB, https://hmdb.ca). A detailed list of the assigned 
metabolites (51 in total) is provided in Online Table  S3. 
Representative 1H NMR spectra of polar metabolites 
extracted from the liver and muscle tissue of a K14- IL- 
17Aind/+ mouse are presented in Online Figure S9. NMR 
spectra (spectral width from 9.50 to 0.60 ppm) were seg-
mented into 1737 chemical shift regions of 0.005  ppm 
width, using the software package AMIX Statistics v. 
3.9.14 (Analysis of MIXtures, Bruker BioSpin), the inte-
grals were calculated and normalized to the total intensity. 
The region of the residual water suppression trace (4.90- 
4.68 ppm) was excluded from the data set.
4.16 | Quantitative real- time reverse- 
transcription polymerase chain reaction (real- 
time RT- PCR)
Total RNA extraction was performed using the standard-
ized method of Trizol isolation as previously shown.42 
Briefly, we lysed and homogenized the tissues in TRIzol® 
(15 596 026, Thermo Fisher) along manufacturer's proto-
col. RNA concentration was measured using the NanoDrop 
spectrophotometer (Thermo Fisher). 0.5 μg of total RNA 
was used for quantitative real- time PCR (qPCR). For 
QuantiTect SYBR Green RT- PCRs, one microgram of 
cDNA was measured. The QuantiTect SYBR Green 
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reaction mixture (204245, Qiagen, Venlo, Netherlands) 
was used on RT- PCR 96- well plates (Roche) with primer 
mixes from Qiagen as described on their homepage. For 
the quantification of mRNA expression, we used the com-
parative delta CT method. The gene expression was nor-
malized to the endogenous control (GAPDH mRNA) and 
the expression of target gene mRNA of each sample was 
expressed relative to that of control.
The following primers were used for QuantiTec- SYBR 
Green TR- PCRs:
Aquaporin 153
forward 5′- GCTTGCCATTGGCTTGTCTG- 3′/reverse 
5′- TGGTTTGAGAAGTTGCGGGT- 3′
Aquaporin 254
forward 5′- GTGGGTTGCCATGTCTCCTT- 3′/reverse 
5′- GTCCCCGCGGATTTCTACAG- 3′
Aquaporin 3
forward 5′- GCCCTCCAGAATTTCTATGAACTCT- 3′/
reverse 5′- TTTGCTATCCTACCTTGGCTTAAAG- 3′
Aquaporin 4
forward 5′- GGGAGAGGTATTGTCTTCCGTATG- 3′/re-
verse 5′- ATGGGTGGCAGGAAATCTGA- 3′
UT- A1
forward 5′- GACAGTGAGACGCAGTGAAG- 3′/reverse 
5′- ACGGTCTCAGAGCTCTCTTC- 3′
UT- A2
forward 5′- TTTCTCCAGTCCTATCTGAG- 3′/reverse 
5′- ACGGTCTCAGAGCTCTCTTC- 3′
UT- A3
forward 5′- ACGGTCTCAGAGCTCTCTTC- 3′/reverse 
5′- AGAGTGGAGGCCACACGGAT- 3′
4.17 | Western blot analysis
For western blot analyses, tissues were mechanically ho-
mogenized after snap freezing in liquid nitrogen. The tis-
sue homogenates were adjusted for protein content using 
Bradford assay, separated by SDS- PAGE, then electroblot-
ted onto PVDF membranes (EMD Millipore). Membranes 
were subsequently incubated overnight at 4°C with the 
following commercially available primary antibodies: rab-
bit polyclonal anti– p- AMPKα (Thr172) antibody (1:1000; 
Cell Signaling Technology; 4188); rabbit polyclonal anti- 
AMPKα antibody (1:1000; Cell Signaling Technology; 
1532), anti– alpha- actinin (1:10 000; Cell Signaling; 3134), 
anti– β- actin (1:10  000; Sigma- Aldrich; A3854) or anti- 
GAPDH antibody (1:10  000; Sigma- Aldrich; G9295), 
anti- UT- A1 antibody (StressMarq Biosciences; SPC- 
406D), rabbit polyclonal anti- TonEBP antibody (1:1000; 
Invitrogen; PA1- 023). Detection was performed by ECL 
with peroxidase conjugated anti- rabbit/mouse second-
ary antibodies (1:5000; Cell Signaling Technology; 
7074/7076). Immunodetection was fulfilled with ECL 
Reagent (34577, Thermo Fisher) and a Fusion FX reader 
(Vilber, Munich, Germany). Antibody- specific bands were 
finally quantified by densitometry with FUSION FX soft-
ware (Vilber).
4.18 | Chemicals
All chemicals were of highest analytical grade from Sigma- 
Aldrich/Merck unless otherwise stated.
4.19 | Human study
All the studied individuals were psoriasis patients of the 
outpatient clinic of the Department of Dermatology at the 
University Medical Center Mainz who were enrolled for a 
regular appointment. All participants gave informed written 
consent to laboratory analyses, clinical examinations, sam-
pling of biomaterial and the use of data records for research 
purposes. Exclusion criteria were insufficient knowledge of 
German language and physical or psychological inability to 
participate in the examinations. The study was designed ac-
cording to the tenets of the revised Helsinki protocol and pro-
tocol and sampling design were approved by the local ethics 
committee and by the local and federal data safety commis-
sioners (Ethics committee Rhineland- Palatinate, Germany, 
approval number 2018- 13105- KliFo). After informed con-
sent, a specialist for dermatology performed clinical exami-
nation including PASI scoring. Afterwards, transepidermal 
water loss (TEWL) was measured with the same Tewameter® 
TM300 (Courage & Khazaka, Cologne, Germany) as used in 
the murine studies. All measurements were taken in the same 
climatized examination room at a room temperature of 21°C. 
For each site, we obtained three consecutive measurements 
and calculated the mean.
4.20 | Statistical analysis
Power calculation as basis for any animal experiment ac-
cording to the federal animal law and was performed using 
G*Power Software Version 3.1.9.2 (HHU Duesseldorf, 
Duesseldorf, Germany). Effect sizes were calculated from 
previously published experiments. All findings shown have 
been reproduced in at least two independent experiments. 
Concerning the metabolites derived from the NMR data, 
buckets integrals generated by AMIX software, normalized 
to spectral total intensity (NMR spectroscopy paragraph) 
were used to calculate signal intensities. Depending on 
the region overlap, one bucket or the sum of buckets were 
used for metabolites statistical analysis. Data are presented 
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depending on their scale and distribution with arithmetic 
mean and standard deviation (mean  ±  SEM) or median 
including 25%- 75% quartiles (25|75). Unless otherwise 
specified, boxplots show median and interquartile range 
(IQR) with whiskers showing minimum and maximum val-
ues, bar graphs show individual values and mean ± SEM. 
Outliers identified by ROUT or Grubbs’ test were excluded. 
Normality was assessed by Kolmogorov- Smirnov normal-
ity test. To compare independent measurements, we used 
two- tailed unpaired student´s t- test and Mann- Whitney U 
test, as appropriate. To compare dependent measurements, 
we used a paired t test or Wilcoxon signed- rank test, as 
appropriate. To compare more than two groups, we used 
one- way ANOVA followed by Tukey's post- hoc test or 
Kruskal- Wallis test followed by Dunn's post hoc test, 
as appropriate. Statistical analysis was performed using 
GraphPad Prism 8 (version 8; GraphPad Software, Inc, La 
Jolla, USA). P- values of P ≤ .05 were considered statisti-
cally significant.
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